Onyx Biotec Limited (NSE:ONYX)
32.60
-1.20 (-3.55%)
At close: Mar 4, 2026
Onyx Biotec Market Cap
Onyx Biotec has a market cap or net worth of 591.11 million as of March 5, 2026. Its market cap has decreased by -39.52% in one year.
Market Cap
591.11M
Enterprise Value
676.50M
Revenue
663.87M
Ranking
n/a
PE Ratio
50.31
Stock Price
32.60
Market Cap Chart
Since November 22, 2024, Onyx Biotec's market cap has decreased from 1.03B to 591.11M, a decrease of -42.55%. That is a compound annual growth rate of -35.16%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 4, 2026 | 591.11M | -20.10% |
| Dec 31, 2025 | 739.79M | -54.46% |
| Dec 31, 2024 | 1.62B | 57.89% |
| Nov 22, 2024 | 1.03B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Makers Laboratories | 837.56M |
| Source Natural Foods and Herbal Supplements | 794.96M |
| Accretion Pharmaceuticals | 756.44M |
| Asston Pharmaceuticals | 681.04M |
| Amwill Health Care | 669.12M |
| Godavari Drugs | 569.16M |
| Phaarmasia | 561.65M |
| Shelter Pharma | 540.78M |